Skip Navigation


Carcinogenesis Advance Access originally published online on April 30, 2009
Carcinogenesis 2009 30(7):1115-1124; doi:10.1093/carcin/bgp105
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
30/7/1115    most recent
bgp105v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Filomeni, G.
Right arrow Articles by Ciriolo, M. R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Filomeni, G.
Right arrow Articles by Ciriolo, M. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

The isatin-Schiff base copper(II) complex Cu(isaepy)2 acts as delocalized lipophilic cation, yields widespread mitochondrial oxidative damage and induces AMP-activated protein kinase-dependent apoptosis

Giuseppe Filomeni1, Sara Piccirillo2, Ilaria Graziani1, Simone Cardaci1, Ana M. Da Costa Ferreira3, Giuseppe Rotilio1,2 and Maria R. Ciriolo1,2,*

1 Department of Biology, University of Rome "Tor Vergata", via della Ricerca Scientifica, 00133 Rome, Italy
2 Research Centre IRCCS San Raffaele Pisana, Via dei Bonacolsi, 00163 Rome, Italy
3 Departamento de Química Fundamental, Instituto de Química, Universidade de Sâo Paulo, PO Box 26077, CEP 05513-10 970, Sâo Paulo, SP, Brazil

* To whom correspondence should be addressed. Tel: +39 06 7259 4369; Fax: +39 06 7259 4311; Email: ciriolo{at}bio.uniroma2.it

We previously demonstrated that Bis[(2-oxindol-3-ylimino)-2-(2-aminoethyl)pyridine-N,N']copper(II) [Cu(isaepy)2] was an efficient inducer of the apoptotic mitochondrial pathway. Here, we deeply dissect the mechanisms underlying the ability of Cu(isaepy)2 to cause mitochondriotoxicity. In particular, we demonstrate that Cu(isaepy)2 increases NADH-dependent oxygen consumption of isolated mitochondria and that this phenomenon is associated with oxy-radical production and insensitive to adenosine diphosphate. These data indicate that Cu(isaepy)2 behaves as an uncoupler and this property is also confirmed in cell systems. Particularly, SH-SY5Y cells show: (i) an early loss of mitochondrial transmembrane potential; (ii) a decrease in the expression levels of respiratory complex components and (iii) a significant adenosine triphosphate (ATP) decrement. The causative energetic impairment mediated by Cu(isaepy)2 in apoptosis is confirmed by experiments carried out with {rho}0 cells, or by glucose supplementation, where cell death is significantly inhibited. Moreover, gastric and cervix carcinoma AGS and HeLa cells, which rely most of their ATP production on oxidative phosphorylation, show a marked sensitivity toward Cu(isaepy)2. Adenosine monophosphate-activated protein kinase (AMPK), which is activated by events increasing the adenosine monophosphate:ATP ratio, is deeply involved in the apoptotic process because the overexpression of its dominant/negative form completely abolishes cell death. Upon glucose supplementation, AMPK is not activated, confirming its role as fuel-sensing enzyme that positively responds to Cu(isaepy)2-mediated energetic impairment by committing cells to apoptosis. Overall, data obtained indicate that Cu(isaepy)2 behaves as delocalized lipophilic cation and induces mitochondrial-sited reactive oxygen species production. This event results in mitochondrial dysfunction and ATP decrease, which in turn triggers AMPK-dependent apoptosis.

Abbreviations: ADP, adenosine diphosphate; AMPK, adenosine monophosphate-activated protein kinase; ATP, adenosine triphosphate; DLC, delocalized lipophilic cation; ROS, reactive oxygen species

Received January 15, 2009; revised March 31, 2009; accepted April 25, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.